← The Wire
NVCTNasdaq
Nuvectis Pharma, Inc.
Pharmaceutical Preparations · DE · CIK 1875558
Nuvectis Pharma develops innovative precision medicines for oncology, focusing on unmet medical needs
$284M
Market cap
$28.53
Last close
+4.9%
1D
+72.6%
5D
519K
Volume
Price · last 39 sessions+220.9%
May 4L $8.89 · H $28.53Jun 29
79
Total filings
Jun 29, 2026
Last filing
12/31
Fiscal year end
424B5424B5Jun 29, 20268-KCompany UpdateJun 29, 20268-KMaterial Agreement · Company UpdateJun 23, 20268-KShareholder VoteJun 12, 202610-Q10-QMay 5, 20268-KResults of OperationsMay 5, 2026DEFA14ADEFA14AApr 27, 2026DEF 14ADEF 14AApr 27, 20268-KResults of OperationsFeb 11, 202610-K10-KFeb 11, 20268-KResults of OperationsNov 4, 202510-Q10-QNov 4, 20258-KExecutive ChangeSep 25, 202510-Q10-QAug 5, 20258-KResults of OperationsAug 5, 20258-KShareholder VoteJun 13, 20258-KCompany UpdateMay 9, 2025424B5424B5May 9, 202510-Q10-QMay 6, 20258-KResults of OperationsMay 6, 2025DEFA14ADEFA14AApr 28, 2025DEF 14ADEF 14AApr 28, 202510-K10-KFeb 25, 20258-KResults of OperationsFeb 25, 2025424B5424B5Feb 6, 20258-KMaterial Agreement · Company UpdateFeb 6, 2025424B5424B5Feb 4, 202510-Q10-QNov 5, 20248-KResults of OperationsNov 5, 20248-KCompany UpdateAug 29, 202410-Q10-QAug 6, 20248-KResults of OperationsAug 6, 20248-KShareholder VoteJun 13, 202410-Q10-QMay 7, 20248-KResults of OperationsMay 7, 2024DEFA14ADEFA14AApr 29, 2024DEF 14ADEF 14AApr 29, 202410-K10-KMar 5, 20248-KResults of OperationsMar 5, 2024SC 13GSCHEDULE 13GFeb 6, 20248-KResults of OperationsNov 8, 202310-Q10-QNov 8, 20238-KCompany UpdateSep 12, 20238-KCompany UpdateAug 17, 20238-KResults of OperationsAug 9, 202310-Q10-QAug 9, 20238-KResults of OperationsJul 3, 20238-KExecutive Change · Shareholder VoteJun 16, 20238-KResults of OperationsMay 15, 202310-Q10-QMay 10, 20238-KResults of OperationsMay 10, 2023DEF 14ADEF 14AApr 28, 2023SC 13GSC 13GApr 3, 202310-K/AFORM 10-K/AMar 27, 202310-K10-KMar 8, 20238-KResults of OperationsMar 7, 2023SC 13GSC 13GFeb 13, 2023SC 13GSC 13GFeb 13, 20238-KResults of OperationsNov 8, 202210-Q10-QNov 8, 2022S-1FORM S-1Aug 15, 202210-Q10-QAug 10, 20228-KResults of OperationsAug 5, 20228-KMaterial Agreement · Equity IssuanceJul 29, 202210-Q10-QMay 12, 20228-KResults of OperationsMay 11, 2022SC 13DSC 13DMar 28, 202210-KFORM 10-KMar 23, 20228-KExecutive Change · Results of OperationsMar 22, 2022SC 13GSC 13GFeb 15, 2022424B4424B4Feb 7, 20228-KMaterial Agreement · Bylaw AmendmentFeb 4, 2022S-1/AS-1/AJan 24, 2022S-1/AS-1/AJan 18, 2022S-1/AS-1/ANov 30, 2021S-1/AS-1/ANov 8, 2021S-1/AS-1/AOct 28, 2021S-1/AS-1/AOct 21, 2021S-1S-1Oct 6, 2021
Insider Activity
◆ Cluster Buy · 4 insidersIn the 90 days to Nov 5, 2025: 4 insiders bought $1.1M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 5, 2025 | Sanchez JuanDirector | Buy | 13,000 | $5.79 | $75K |
| Nov 5, 2025 | Kaplan Matthew L.Director | Buy | 11,000 | $5.84 | $64K |
| Nov 5, 2025 | Bentsur RonChairman & CEO | Buy | 5,000 | $5.72 | $29K |
| Oct 27, 2025 | Mosseri Marlio CharlesTenPercentOwner | Buy | 72,836 | $6.28 | $457K |
| Oct 24, 2025 | Mosseri Marlio CharlesTenPercentOwner | Buy | 35,034 | $6.15 | $215K |
| Oct 23, 2025 | Mosseri Marlio CharlesTenPercentOwner | Buy | 46,900 | $6.06 | $284K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance